Positive Publication news for Lymphoseek has no major' surprises so stock doesnt react that much.
Lymphoseek sales,EU partnership,officialy ending the H&N trial are some of the material events that should have better results in the rise of share price..
Just a matter of time.
its obvious this stock is dead. The whole thing has been a bunch of nonsense from the start. All those analysts dont have a clue lifetech, JMP, all said 5-7 on approval, not one has explained why its 2.43. The analysts did not say 6-12 months after approval they said on approval. What is taking so long for the Euro partner another piece of news that supposed to help, I doubt it will. If the market loved NAVB there would be more volume and more buyers at 2.43, but there isn't. You cannot blame the shorts for no volume and no buying interest. I guess the market doesn't like this product or they think it will fail or require cash from stock offerings. This is hanging over the share price not letting it move. This is the only logical explanation.
its obvious you are not an economics major, all things being equall it may have been, however the shorts were a variable that was not in the mix, only the perceived value of the product and pipe line were and are a pare of analysts projections. This is a great opportunity and I am happy the shorts are here. It gives me more opportunity to purchase at these low prices.
I enjoy reading the blogs of uneducated science and wall street on this board, it only allows me to understand the competition and how ignorant and uneducated they seem to be. Hopefully it is others minds not there's